These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21372302)

  • 21. Impact of gender on statin efficacy.
    Dale KM; Coleman CI; Shah SA; Patel AA; Kluger J; White CM
    Curr Med Res Opin; 2007 Mar; 23(3):565-74. PubMed ID: 17355737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study.
    Holme I; Szarek M; Cater NB; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Larsen ML; Lindahl C; Pedersen TR;
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):315-20. PubMed ID: 19322096
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacoutilization of statin therapy after acute myocardial infarction. A real practice analysis based on administrative data.
    Degli Esposti L; Di Martino M; Saragoni S; Valpiani G; Capone A; Corvi E; Degli Esposti E
    Ital Heart J; 2004 Feb; 5(2):120-6. PubMed ID: 15086141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-related effect of statins on atrial fibrillation after cardiac surgery.
    Kourliouros A; De Souza A; Roberts N; Marciniak A; Tsiouris A; Valencia O; Camm J; Jahangiri M
    Ann Thorac Surg; 2008 May; 85(5):1515-20. PubMed ID: 18442529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure to achieve recommended LDL cholesterol levels by suboptimal statin therapy relates to elevated cardiac event rates.
    Baessler A; Fischer M; Huf V; Mell S; Hengstenberg C; Mayer B; Holmer S; Riegger G; Schunkert H
    Int J Cardiol; 2005 May; 101(2):293-8. PubMed ID: 15882678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells.
    Thum T; Fraccarollo D; Galuppo P; Tsikas D; Frantz S; Ertl G; Bauersachs J
    Cardiovasc Res; 2006 Apr; 70(1):50-60. PubMed ID: 16480696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
    Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
    J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of ezetimibe/simvastatin 10/40 mg compared to doubling the dose of low-, medium- and high-potency statin monotherapy in patients with a recent coronary event.
    Brudi P; Reckless JP; Henry DP; Pomykaj T; Lim ST; Massaad R; Vandormael K; Johnson-Levonas AO
    Cardiology; 2009; 113(2):89-97. PubMed ID: 19018143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of simvastatin on Kruppel-like factor2, endothelial nitric oxide synthase and thrombomodulin expression in endothelial cells under shear stress.
    Rossi J; Rouleau L; Tardif JC; Leask RL
    Life Sci; 2010 Jul; 87(3-4):92-9. PubMed ID: 20493886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin therapy is associated with improved cardiovascular outcomes and levels of inflammatory markers in patients with heart failure.
    Sola S; Mir MQ; Rajagopalan S; Helmy T; Tandon N; Khan BV
    J Card Fail; 2005 Oct; 11(8):607-12. PubMed ID: 16230264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of endothelial dysfunction with simvastatin in patients with autosomal dominant polycystic kidney disease.
    Namli S; Oflaz H; Turgut F; Alisir S; Tufan F; Ucar A; Mercanoglu F; Ecder T
    Ren Fail; 2007; 29(1):55-9. PubMed ID: 17365910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
    Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simvastatin decreases nitric oxide overproduction and reverts the impaired vascular responsiveness induced by endotoxic shock in rats.
    Giusti-Paiva A; Martinez MR; Felix JV; da Rocha MJ; Carnio EC; Elias LL; Antunes-Rodrigues J
    Shock; 2004 Mar; 21(3):271-5. PubMed ID: 14770041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy.
    Silva M; Matthews ML; Jarvis C; Nolan NM; Belliveau P; Malloy M; Gandhi P
    Clin Ther; 2007 Feb; 29(2):253-60. PubMed ID: 17472818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simvastatin elicits dilation of isolated porcine retinal arterioles: role of nitric oxide and mevalonate-rho kinase pathways.
    Nagaoka T; Hein TW; Yoshida A; Kuo L
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):825-32. PubMed ID: 17251484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose statin, not so IDEAL?
    Vos E
    J Am Coll Cardiol; 2010 Jun; 55(22):2516-7. PubMed ID: 20510223
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease.
    van der Harst P; Wagenaar LJ; Buikema H; Voors AA; Plokker HW; Morshuis WJ; Six AJ; Boonstra PW; Nickenig G; Wassmann S; van Veldhuisen DJ; van Gilst WH
    Am J Cardiol; 2005 Nov; 96(10):1361-4. PubMed ID: 16275178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of previous treatment with statins on outcome of patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Lev EI; Kornowski R; Vaknin-Assa H; Ben-Dor I; Brosh D; Teplitsky I; Fuchs S; Battler A; Assali A
    Am J Cardiol; 2009 Jan; 103(2):165-9. PubMed ID: 19121430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of short-term rosuvastatin therapy on endothelial progenitor cells and endothelial function.
    Pirro M; Schillaci G; Romagno PF; Mannarino MR; Bagaglia F; Razzi R; Pasqualini L; Vaudo G; Mannarino E
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):14-21. PubMed ID: 19158317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simvastatin reduces myocardial infarct size via increased nitric oxide production in normocholesterolemic rabbits.
    Bao N; Ushikoshi H; Kobayashi H; Yasuda S; Kawamura I; Iwasa M; Yamaki T; Sumi S; Nagashima K; Aoyama T; Kawasaki M; Nishigaki K; Takemura G; Minatoguchi S
    J Cardiol; 2009 Feb; 53(1):102-7. PubMed ID: 19167645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.